Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ebola outbreak in DRC ‘second worst in history’
The Ministry of Health recently announced that the first ever multi-drug Ebola trial will begin in DRC.
Country reports 440 cases since outbreak began

An Ebola outbreak in the Democratic Republic of the Congo (DRC) is the second largest in history, according to the World Health Organisation (WHO).

Peter Salama, WHO’s deputy director-general, said on Twitter last week: ‘The #Ebola outbreak in #DRC is now second largest historically. A sad toll, with too many families losing loved ones.

‘@WHO and partners will continue to stand shoulder-to-shoulder with @MinSanteRDC to do whatever it takes to bring the outbreak to an end.’

As of 1 December, there had been a total of 440 Ebola cases in DRC, with 392 confirmed and 48 probable. So far, 255 people have died since the outbreak was declared around five months ago.

WHO said responding to the outbreak continues to be a challenge, but the Ministry of Health, WHO and partners are focusing their activities in areas where transmission continues - in Butembo, Katwa, Beni and Kalunguta.

Community engagement remains difficult in Katwa, despite significant progress. Improvements are needed to address the high proportion of cases that were not previously registered as contacts and therefore not followed up by surveillance teams.

Insecurity in the eastern part of the country has also posed a challenge in responding to the Ebola threat. In September, health workers were forced to halt vaccinations and tracing people who had been in contact with suspected Ebola patients, owing to a deadly rebel attack.

In a recent statement, WHO said the risk of the outbreak spreading to other provinces in DRC, as well as to other countries, remains very high.

The Ministry of Health recently announced that the first ever multi-drug Ebola trial will begin in DRC, to evaluate the safety and efficacy of drugs.

“While our focus remains on bringing this outbreak to an end, the launch of the randomized control trial in DRC is an important step towards finally finding an Ebola treatment that will save lives,” said WHO director-general Dr Tedros Adhanom Ghebreyesus.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.